SDI Acquisition Faces Uncertainty Despite Strong Board and Shareholder Support

Scheme Booklet Dispatch Marks Key Step in Acquisition

SDI Limited (ASX:SDI) has taken a decisive step forward in its proposed acquisition by InnoXvest Dental Pty. Ltd, a subsidiary of Beijing Guoci Kebo Technology Co., Ltd, by dispatching the Scheme Booklet to shareholders. The booklet outlines the terms of the all-cash offer of A$1.40 per share, which values SDI at a notable premium and sets the stage for the upcoming shareholder vote.

This dispatch follows the recent ASIC registration of the Scheme Booklet and court approval to convene the shareholder meeting, reinforcing regulatory progress for the deal. Shareholders will consider the acquisition at a virtual meeting scheduled for 22 June 2026, with voting options including online attendance or proxy submission by 20 June.

Strong Shareholder and Board Support Underlines Positive Momentum

Backing the acquisition, SDI’s Chairman Jeffery Cheetham and Currango Pastoral Company, the largest shareholder controlling about 45.3% of shares, have confirmed their intention to support the Scheme. This endorsement is contingent on no superior proposal emerging and the Independent Expert maintaining a positive view that the Scheme is in shareholders’ best interests.

Similarly, the entire SDI Board has unanimously recommended shareholders vote in favour, with each director committing to vote their shares accordingly under the same conditions. This unified stance provides a solid foundation for the Scheme’s approval, assuming no unexpected developments.

Acquisition Reflects SDI’s Strategic Position in Dental Materials

SDI is a well-established manufacturer and global distributor of specialist dental materials, producing restorative products such as amalgams, composites, adhesives, and tooth whitening systems from its Victoria base. The company has faced headwinds from regulatory changes affecting amalgam sales but has diversified into aesthetics and exports, as highlighted in its recent financial updates.

The acquisition by Beijing Guoci, a subsidiary of Shandong Sinocera Functional Material Co. Ltd, aligns with the latter’s global expansion in advanced materials and dental businesses. The proposed deal could offer SDI access to broader markets and resources, although the final outcome hinges on shareholder approval and regulatory clearances.

SDI’s recent financial performance showed resilience amid sector challenges, with modest profit dips offset by sales growth in key regions. The company’s ongoing Montrose project and product innovation efforts underscore its strategic initiatives to maintain competitiveness, factors likely considered in the valuation and acquisition rationale. These operational dynamics were detailed in prior reports on SDI’s modest profit dip and acquisition talks and margin gains and Montrose project progress.

Next Steps Focus on Shareholder Vote and Expert Assessments

With the Scheme Booklet now in shareholders’ hands, attention turns to the virtual Scheme Meeting on 22 June. Shareholders will weigh the merits of the A$1.40 per share offer amidst the Independent Expert’s continuing assessment. The absence of a superior proposal remains a critical caveat, leaving open the possibility of competing bids.

Investors should monitor the voting outcomes and any new developments closely, as these will determine whether the acquisition proceeds or if SDI remains independent. The transaction’s completion will also depend on further regulatory approvals, including FIRB and Chinese authorities, adding layers of complexity to the deal’s timeline.